Global Cardiac Rhythm Management Devices Batteries Market, By Product Type (Implantable Cardiac Pacemaker, Implantable Cardioverter Defibrillator, and Cardiac Resynchronization Device), By Power Source (Lithium-Iodine Cells, Lithium-Silver Vanadium Oxide Cell, Lithium-Carbon Monofluride Cells, and Lithium-Manganese Dioxide), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Published In : Jan 2024

Code : CMI3173

Pages :165

Formats :

Excel and PDF

Industry : Medical Devices

Cardiac Rhythm Management Devices Batteries MarketSize and Trends

The global cardiac rhythm management devices batteries market size is estimated to be at US$ 520.3 Mn in 2023 and is expected to reach US$ 700.7 Mn by 2030, growing at a compound annual growth rate (CAGR) of 4.3% from 2023 to 2030.

The global cardiac rhythm management devices batteries market has been experiencing a phase of steady growth over the past decade, driven by the rising prevalence of cardiac abnormalities worldwide. Cardiac rhythm management (CRM) devices help regulate heartbeat rhythm disorders and include pacemakers, implantable cardioverter defibrillators (ICDs), and cardiac resynchronization therapy devices (CRT-Ds). Powering these implantable and life-saving devices are lithium-ion batteries that require periodic replacement. Advances in battery technology have allowed the development of smaller, longer-lasting batteries, expanding the potential patient pool for CRM devices. Growing geriatric population that is more susceptible to arrhythmias, rising economic ability to afford these devices, and increasing awareness about effective cardiac condition management are the key factors expected to propel the demand for CRM device batteries in the coming years.

Global Cardiac Rhythm Management Devices Batteries Market Trends:

Miniaturization of devices: The trend of miniaturization of devices has significantly influenced the global cardiac rhythm management devices batteries market in recent years. With advancements in microchip technology, battery and medical device manufacturers are able to pack more computing power and battery capacity into increasingly smaller form factors. This allows for the development of significantly smaller implantable cardiac devices like pacemakers and defibrillators.
Battery capacity improvement: The continual advancement in battery technology is significantly impacting the cardiac rhythm management devices batteries market. Medical device manufacturers are focusing on developing miniature batteries with higher power density, and longer lifespan to keep pace with the miniaturization of cardiac devices. The demand for implantable cardioverter defibrillator and pacemaker replacement has been rising in recent years mainly due to improvements in battery longevity.
Integration of AI into devices: The integration of artificial intelligence (AI) capabilities into cardiac rhythm management devices is significantly impacting the global cardiac rhythm management devices batteries market for these products. AI functionalities allow for more advanced monitoring, diagnostics, and personalization of therapy which improves patient outcomes. However, it also increases the computational and power requirements of the devices. Manufacturers are having to design batteries with higher energy densities that can last longer while supporting new AI-backed features.